Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor.
pathological features
renal
well-differentiated neuroendocrine tumor
Journal
OncoTargets and therapy
ISSN: 1178-6930
Titre abrégé: Onco Targets Ther
Pays: New Zealand
ID NLM: 101514322
Informations de publication
Date de publication:
2022
2022
Historique:
received:
01
03
2022
accepted:
23
05
2022
entrez:
3
6
2022
pubmed:
4
6
2022
medline:
4
6
2022
Statut:
epublish
Résumé
Primary carcinoid tumor of the kidney is an extremely rare well-differentiated neuroendocrine tumor, which is generally a low-grade malignant cancer with a good prognosis. Carcinoid tumors are rarely found in the urinary system. Here, we report a 34-year-old woman with primary renal well-differentiated neuroendocrine tumor who underwent nephron sparing surgery and no evidence of recurrence or distant metastasis was found during routine follow-up. We searched the case of renal carcinoid with the search phrase "carcinoid [title] and kidney [title]" and "carcinoid [title] and renal [title]" using the PubMed and restricted the search to articles published in English since 2013. The clinical manifestations, age, sex, tumor size, location, gross pathology, light microscopy and immunohistochemistry were analyzed. A total of 28 cases of renal carcinoid were retrieved from PubMed. Higher proportion of positive labeling of CgA, Syn, NSE and CD56 are most valuable in the diagnosis of primary renal well-differentiated neuroendocrine tumor. At present, radical nephrectomy remains the gold standard in the curative-intent therapy for well-differentiated neuroendocrine carcinoma of kidney, in metastatic renal carcinoid, long-term use of octreotide may be an effective adjuvant therapy.
Identifiants
pubmed: 35655605
doi: 10.2147/OTT.S364545
pii: 364545
pmc: PMC9153994
doi:
Types de publication
Case Reports
Langues
eng
Pagination
587-596Informations de copyright
© 2022 Jiang and Zhang.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
BMC Urol. 2010 Dec 14;10:22
pubmed: 21144059
J Ultrasound Med. 2004 Mar;23(3):433-7
pubmed: 15055793
Onco Targets Ther. 2016 Feb 23;9:741-3
pubmed: 26966374
Radiol Case Rep. 2015 Dec 07;9(2):923
pubmed: 27186242
Nephron. 1987;47(2):131-3
pubmed: 3696318
J Urol. 2008 Nov;180(5):2193
pubmed: 18804792
Diagn Cytopathol. 1995 Jun;12(4):360-3
pubmed: 7656761
J Gastroenterol Hepatol. 2020 Mar;35(3):359
pubmed: 31786821
Hum Pathol. 2004 Jul;35(7):825-31
pubmed: 15257545
J Clin Pathol. 2001 Jul;54(7):498-9
pubmed: 11429418
Clin Chem. 1994 Jan;40(1):86-95
pubmed: 7507008
Int Urol Nephrol. 2007;39(2):373-6
pubmed: 16835722
Rare Tumors. 2019 Oct 23;11:2036361319878915
pubmed: 31692698
Oncol Lett. 2015 Jul;10(1):449-452
pubmed: 26171049
Clin Nucl Med. 2015 Sep;40(9):e446-7
pubmed: 26164175
Nephrol Dial Transplant. 1996 Dec;11(12):2489-90
pubmed: 9017629
Perm J. 2020;24:
pubmed: 32240087
J Pathol Bacteriol. 1963 Apr;85:441-4
pubmed: 13949182
Urol Case Rep. 2017 Jan 10;11:39-41
pubmed: 28083486
Cancer. 1976 Oct;38(4):1636-40
pubmed: 991082
Urol Case Rep. 2018 Aug 09;21:14-16
pubmed: 30128296
Pathol Oncol Res. 2020 Jan;26(1):341-346
pubmed: 30357753
Urology. 2005 Sep;66(3):658
pubmed: 16140109
Int J Clin Exp Pathol. 2013 Oct 15;6(11):2578-84
pubmed: 24228123
Endocr Pathol. 2022 Mar;33(1):115-154
pubmed: 35294740
Clin Nucl Med. 2011 Nov;36(11):1025-8
pubmed: 21975394
Radiol Case Rep. 2015 Nov 06;1(3):108-11
pubmed: 27298696
Pathol Int. 2008 Jan;58(1):51-4
pubmed: 18067641
Arch Pathol Lab Med. 2002 Aug;126(8):979-81
pubmed: 12171501
Can Urol Assoc J. 2009 Jun;3(3):E7-E9
pubmed: 19543456
Histopathology. 2021 Jan;78(1):162-170
pubmed: 33382490
Pathology. 2003 Aug;35(4):353-5
pubmed: 12959775
J Thorac Oncol. 2019 Feb;14(2):184-192
pubmed: 30414942
J Nucl Med. 2006 Oct;47(10):1732; author reply 1732
pubmed: 17015913
Nucl Med Commun. 2012 Mar;33(3):322-30
pubmed: 22183015
J Exp Clin Cancer Res. 1999 Jun;18(2):133-41
pubmed: 10464698
Diagn Pathol. 2007 May 17;2:15
pubmed: 17509135
Ophthalmic Plast Reconstr Surg. 2015 Jul-Aug;31(4):e91-3
pubmed: 24777267
Am J Med Sci. 2012 Jan;343(1):106-8
pubmed: 22008780
Lung India. 2017 Jul-Aug;34(4):383-385
pubmed: 28671173
J Urol. 1997 Jun;157(6):2059-66
pubmed: 9146580
J Pathol Bacteriol. 1965 Oct;90(2):686-90
pubmed: 4158762
Dig Dis Sci. 2016 Mar;61(3):708-12
pubmed: 26715503
Surg Oncol Clin N Am. 1999 Jan;8(1):145-69
pubmed: 9824366
Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):e49-e57
pubmed: 27753663
Arch Ital Urol Androl. 2017 Dec 31;89(4):316-318
pubmed: 29473385
Saudi J Kidney Dis Transpl. 2013 Sep;24(5):988-90
pubmed: 24029267
Case Rep Pathol. 2017;2017:9672368
pubmed: 28620558
Diagn Pathol. 2009 Jun 14;4:17
pubmed: 19523243
Urology. 1988 Jun;31(6):517-20
pubmed: 2453967
Pathol Int. 2016 Jan;66(1):42-6
pubmed: 26644387
J Urol. 2006 Dec;176(6 Pt 1):2359-66
pubmed: 17085102
Urol Case Rep. 2016 May 27;7:70-1
pubmed: 27335800
Oncol Lett. 2010 Jan;1(1):87-90
pubmed: 22966261
BMJ Case Rep. 2016 Mar 07;2016:
pubmed: 26951438
Crit Rev Oncol Hematol. 2013 Sep;87(3):256-64
pubmed: 23478151
Histopathology. 2019 Jul;75(1):104-117
pubmed: 30851202
J Environ Pathol Toxicol Oncol. 1994;13(4):269-71
pubmed: 7658337
Diagn Pathol. 2015 Oct 06;10:182
pubmed: 26445413
Ultrastruct Pathol. 2018 Jan-Feb;42(1):18-22
pubmed: 29192809
J Clin Oncol. 2009 Oct 1;27(28):4656-63
pubmed: 19704057
Med Times. 1966 Aug;94(8):895-6
pubmed: 5938842